Zimbabwe has rejected a significant American health deal worth 367 million US dollars (£272m) spanning five years due to Washington's insistence on confidential information.
This move came to light after a official document from December was disclosed, revealing that Head of State Emmerson Mnangagwa deemed the deal was "unbalanced".
An official representative later explained that the United States was demanding access to biological samples for research and commercial gain while refused to guarantee the benefits from future medical innovations.
"We must now begin the challenging and unfortunate task of scaling back our health aid in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy noted the United States had provided more than $1.9bn in health funding to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has urged more talks to secure a agreement acceptable to both sides so the country's vital HIV programme can be sustained.
Wider Implications
Zimbabwe's decision follows a comparable case in Kenya, where a court halted a similar health funding agreement following legal challenges were raised about the security of Kenyans' health data.
After resuming office last year, US President Donald Trump has slashed foreign aid and closed the US Agency for International Development (USAID).
The agency had managed assistance for the American government, but Trump stated its expenditure was "inefficient" and his government was pursuing government-to-government agreements to enhance openness and responsibility.
As per reports, Sixteen nations in Africa have to date signed similar agreements, constituting more than $18.3bn in committed funds.
Details of the Rejected Agreement
This assistance for Zimbabwe would have supported "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this collaboration might have yielded extraordinary benefits for the people of Zimbabwe, particularly the 1.2 million currently receiving HIV treatment via American-funded programmes," Tremont added.
However, official spokesman Nick Mangwana said the arrangement was "unequal".
"The proposal required Zimbabwe to share its genetic material and health information for a long time, with no equivalent promise of access to any medical innovations – such as vaccines, diagnostics, or treatments – that might be developed from that provided information," Mangwana explained.
"Effectively, our country would provide the raw materials for medical research without any certainty that the resulting innovations would be available to our population if a future health crisis arise."
National Interest and International Frameworks
Mangwana further said that the American exit from the World Health Organization (WHO) and its push of bilateral deals were upending systems previously established through the global organization.
The spokesperson cited its Pandemic Benefit-Sharing framework designed to manage future global health emergencies.
"This framework is intended to guarantee that when a country contributes its information, the benefits – such as vaccines and treatments – are distributed fairly, not monopolised exclusively by those with the funds to develop them."
These objections regarding the US deal "are not meant as opposition to America," he added.
"We encourage further dialogue with our US partners on how subsequent collaboration might be designed in a manner that respects the independence and dignity of each country."
Health Experts Reaction
Medical experts said it understood the government's concerns, but urged that negotiations need to persist considering a large portion of the country's Aids initiatives relied on external financing.
"If technical issues exist, including those involving data governance or implementation frameworks, these can often be resolved via technical clarification and negotiated safeguards," it said.
This impasse highlights the complex debate between receiving much-needed international aid and safeguarding national sovereignty in an ever more interconnected world.